CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -232.0%, against -137.6% the year before. The highest annual figure on record is -79.6% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -232.0% | −94.5 |
| FY2024 | Dec 31, 2024 | -137.6% | −58.0 |
| FY2023 | Dec 31, 2023 | -79.6% | +15.6 |
| FY2022 | Dec 31, 2022 | -95.1% | +26.4 |
| FY2021 | Dec 31, 2021 | -121.5% | +197.4 |
| FY2020 | Dec 31, 2020 | -318.9% | – |
See a number that looks wrong?